Becton, Dickinson and Company (BDXB) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Instruments & Supplies secteur d'activité. Le siège social de l'entreprise est situé à Franklin Lakes, NJ, United States. Le PDG actuel est Thomas E. Polen Jr..
BDXB a date d'introduction en bourse 2020-05-21, 77,000 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $13.69B.
Becton, Dickinson and Company is a global leader in medical technology, developing, manufacturing, and distributing a comprehensive portfolio of medical supplies, devices, laboratory equipment, and diagnostic products. The company serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry through three primary business segments: BD Medical, which provides IV catheters, infusion systems, syringes, diabetes care products, and medication management solutions; BD Life Sciences, which offers specimen collection, microbiology automation, molecular testing systems, and cell analysis instruments; and BD Interventional, which specializes in surgical products, grafts, and critical care devices. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, Becton Dickinson operates worldwide to advance patient care and clinical outcomes across multiple healthcare settings.
